Ken-ichi Kitazoe

Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2

Takashi Oshima, Masahiro Abe, Jin Asano et al. · Blood · 2005 · 344 citations · Full text

Medicine, Cancer Biology, Oncology +13

Myeloma Cell-Osteoclast Interaction Enhances Angiogenesis Together with Bone Resorption: A Role for Vascular Endothelial Cell Growth Factor and Osteopontin

Yoïchi Tanaka, Masahiro Abe, Masahiro Hiasa et al. · Clinical Cancer Research · 2007 · 172 citations

Medicine, Cancer Biology, Oncology +17

Therapy with Bortezomib plus Dexamethasone Induces Osteoblast Activation in Responsive Patients with Multiple Myeloma

Shuji Ozaki, Osamu Tanaka, Shiro Fujii et al. · International Journal of Hematology · 2007 · 55 citations

Medicine, Pharmacology, Pharmacotherapy +16

Valproic acid exerts anti-tumor as well as anti-angiogenic effects on myeloma

Ken-ichi Kitazoe, Masahiro Abe, Masahiro Hiasa et al. · International Journal of Hematology · 2008 · 29 citations

Medicine, Oncology, Pharmacology +13

Malignant B-Lymphoid Cells with Bone Lesions Express Receptor Activator of Nuclear Factor-κB Ligand and Vascular Endothelial Growth Factor to Enhance Osteoclastogenesis

Hironobu Shibata, Masahiro Abe, Kenji Hiura et al. · Clinical Cancer Research · 2005 · 20 citations

Medicine, Oncology, Pathology +17